Analgesic Effect of Ketamine in Patients Undergoing Hysteroscopic Endometrial Thermal Ablation Surgery
N/A
18 Years
65 Years
18 Years
65 Years
Open (Enrolling)
Female
Pain
Female
Pain
Trial Information
Analgesic Effect of Ketamine in Patients Undergoing Hysteroscopic Endometrial Thermal Ablation Surgery
Inclusion Criteria:
- Gender: Female
- Age: 18-65 years
- Non-pregnant, non-lactating
- Surgery: Outpatient hysteroscopic Novasure® endometrial ablation
- Language: English speaking
- Consent: Obtained
Exclusion Criteria:
- Patient refusal
- Under 18 or over age 65
- Non-English Speaking
- Pregnancy, Breast feeding
- Hysteroscopic procedures using Thermachoice® ablation device
- Chronic use or addiction to opiates, sedatives, non-opiate analgesics
- History of heavy alcohol usage (>4 drinks/day)
- Significant cardiovascular or pulmonary disease
- Psychiatric or emotional disorder
- Allergy to anesthetic agents utilized in the protocol
- Glaucoma
- Thyrotoxicosis
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Outcome Measure:
Total dose of postoperative opioid
Outcome Description:
Total dose of opioids will be determined for up to 24 hours post operatively
Outcome Time Frame:
24 hours post operatively
Safety Issue:
No
Principal Investigator
Shireen Ahmad, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Northwestern University
Authority:
United States: Institutional Review Board
Study ID:
STU00026695
NCT ID:
NCT01106846
Start Date:
February 2010
Completion Date:
June 2014
Related Keywords:
- Pain
- Ketamine
- Anesthesia
- Pain
- Outpatient surgery
- Adenoma
Name | Location |
|---|---|
| Northwestern University | Chicago, Illinois 60611 |
| Prentice Women's Hosptial | Chicago, Illinois 60611 |
